Growth Metrics

Precision Biosciences (DTIL) Cash from Investing Activities (2018 - 2026)

Precision Biosciences (DTIL) reported Cash from Investing Activities of -$114000.0 for Q1 2026, up 63.69% year-over-year from -$69642.0 in Q1 2025, and up 64.92% on a QoQ basis from -$325000.0 in Q4 2025.

Precision Biosciences (DTIL) has 9 years of Cash from Investing Activities data on file, last reported at -$114000.0 in Q1 2026.

  • Quarterly Cash from Investing Activities rose 63.69% year-over-year to -$114000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$434000.0 (up 13.72% YoY) and the FY2025 annual result came in at -$634000.0, down 194.88% from the prior year.
  • Cash from Investing Activities improved to -$114000.0 in Q1 2026 per DTIL's latest filing, from -$325000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $7.6 million in Q3 2023 and bottomed at -$1.1 million in Q3 2022.
  • The 5-year median for Cash from Investing Activities is -$114000.0 (2026), against an average of $91000.0.
  • The widest annual swing landed in 2023, when Cash from Investing Activities soared 793.94%; it then slumped 1107.69% in 2025.
  • Tracing DTIL's Cash from Investing Activities over 5 years: stood at -$632000.0 in 2022, then surged by 106.65% to $42000.0 in 2023, then plunged by 330.95% to -$97000.0 in 2024, then plunged by 235.05% to -$325000.0 in 2025, then jumped by 64.92% to -$114000.0 in 2026.
  • Per Business Quant, the three latest DTIL Cash from Investing Activities figures stand at -$114000.0 (Q1 2026), -$325000.0 (Q4 2025), and $17000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -2.89 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 638.50 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -431.90 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -428.90 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -25.54 Mn
10 Precision Biosciences 171.70 Mn 70.52 Mn - -114,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -114,000.00
Mar 31, 2026 -114,000.00
Dec 31, 2025 -325,000.00
Dec 31, 2025 -325,000.00
Sep 30, 2025 17,000.00
Sep 30, 2025 17,000.00
Jun 30, 2025 -12,000.00
Jun 30, 2025 -12,000.00
Mar 31, 2025 -314,000.00
Mar 31, 2025 -314,000.00
Dec 31, 2024 -97,000.00
Dec 31, 2024 -97,000.00
Sep 30, 2024 -64,000.00
Sep 30, 2024 -64,000.00
Jun 30, 2024 -28,000.00
Jun 30, 2024 -28,000.00
Mar 31, 2024 -26,000.00
Mar 31, 2024 -26,000.00
Dec 31, 2023 42,000.00
Dec 31, 2023 42,000.00
Sep 30, 2023 7.56 Mn
Sep 30, 2023 7.56 Mn
Jun 30, 2023 -1.06 Mn
Jun 30, 2023 -1.06 Mn
Mar 31, 2023 -721,000.00
Mar 31, 2023 -721,000.00
Dec 31, 2022 -632,000.00
Dec 31, 2022 -632,000.00
Sep 30, 2022 -1.09 Mn
Sep 30, 2022 -1.09 Mn
Jun 30, 2022 -779,000.00
Jun 30, 2022 -779,000.00
Mar 31, 2022 -818,000.00
Mar 31, 2022 -818,000.00
Dec 31, 2021 -1.51 Mn
Dec 31, 2021 -1.51 Mn
Sep 30, 2021 -1.48 Mn
Sep 30, 2021 -1.48 Mn
Jun 30, 2021 -1.69 Mn
Jun 30, 2021 -1.69 Mn
Mar 31, 2021 -1.13 Mn
Mar 31, 2021 -1.13 Mn
Dec 31, 2020 -1.10 Mn
Dec 31, 2020 -1.10 Mn
Sep 30, 2020 -1.05 Mn
Sep 30, 2020 -1.05 Mn
Jun 30, 2020 -1.79 Mn
Jun 30, 2020 -1.79 Mn
Mar 31, 2020 -1.10 Mn
Mar 31, 2020 -1.10 Mn
Dec 31, 2019 -5.53 Mn
Dec 31, 2019 -5.53 Mn
Sep 30, 2019 -5.92 Mn
Sep 30, 2019 -5.92 Mn
Jun 30, 2019 -8.14 Mn
Jun 30, 2019 -8.14 Mn
Mar 31, 2019 -5.08 Mn
Mar 31, 2019 -5.08 Mn
Dec 31, 2018 -9.87 Mn
Dec 31, 2018 -9.87 Mn
Sep 30, 2018 -4.05 Mn
Sep 30, 2018 -4.05 Mn
Jun 30, 2018 -1.13 Mn
Jun 30, 2018 -1.13 Mn
Mar 31, 2018 -619,000.00
Mar 31, 2018 -619,000.00